Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 801, Issue 2, 2004, Pages 339-345

  Caudron, E ^a   Laurent, S ^a   Billaud, E M ^a   Prognon, P ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Bisoprolol; Celiprolol; Irbesartan

Indexed keywords

BODY FLUIDS; DIODES; EXTRACTION; LIQUID CHROMATOGRAPHY; PATIENT MONITORING;

DIODE ARRAY DETECTION;

DRUG PRODUCTS;

ACEBUTOLOL; ACETYLSALICYLIC ACID; ACID; ANTIHYPERTENSIVE AGENT; ATENOLOL; BASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CAFFEINE; CANDESARTAN; CAPTOPRIL; CARVEDILOL; CELIPROLOL; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; IRBESARTAN; LABETALOL; LISINOPRIL;

ACCURACY; ACIDITY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DEVICE; DIODE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG MONITORING; ELUTION; HUMAN; PLASMA; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

EID: 1642482440     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2003.11.009     Document Type: Article

References (28)

1. McVeigh G.E., Flack J., Gimm R. Drugs. 49:1995;161.
2. Taler S.J., Taxtor S.C., Augustine J.E. Hypertension. 39:2002;982.
3. Yakovlevitch M., Black H.R. Arch. Int. Med. 151:1991;1786.
4. Guidelines Committee. J. Hypertens. 21 (2003) 1011.
5. Kostis J.B., Vachharajani N.N., Hadjilambris O.W., Kollia G.D., Palmisano M., Marino M.R. J. Clin. Pharmacol. 41:2001;935.
6. Leopold G., Pabst J., Ungethum W.et al. J. Clin. Pharmacol. 26:1986;616.
7. Silke B., Thompson A., Leitch A., Riddell J.G. Br. J. Clin. Pharmacol. 40:1995;37.
8. Eastwood R.J., Jerman J.C., Bhamra R.K., Holt D.W. Biomed. Chromatogr. 4:1990;178.
9. Suzuki T., Horikiri Y., Mizobe M., Noda K. J. Chromatogr. 619:1993;267.
10. Verbesselt R., Zugravu A., Tjandramaga T.B., De Schepper P.J. J. Chromatogr. B. 683:1996;231.
11. Chiu F.C.K., Raymond K. J. Chromatogr. B. 687:1996;462.
12. Braza A.J., Modiamio P., Marino E.L. J. Chromatogr. B. 718:1998;267.
13. Ruiz-Angel M.J., Carda-Broch S., R Torres-Laprasió J., Simó-Alfonso E.F., García-Alvarez-Coque M.C. Anal. Chem. Acta. 454:2002;109.
14. Bühring K.U., Garbe A. J. Chromatogr. 382:1986;225.
15. Modiamio P., Lastra C.F., Mariño E.L. J. Pharm. Biomed. Anal. 14:1996;401.
16. Modamio P., Lastra C.F., Montejo O., Mariño E.L. Int. J. Pharm. 130:1996;137.
17. Ruiz-Angel M.J., Torres-Lapasio J.R., Carda-Broch S., Garcia-Alvarez-Coque M.C. J. Chromatogr. Sci. 41:2003;350.
18. Seki T., Yamazaki K., Kayano M. J. Chromatogr. B. 688:1997;101.
19. Chang S.Y., Whigan D.B., Vachharajani N.N., Patel R. J. Chromatogr. B. 702:1997;149.
20. González L., López J.A., Alonso R.M., Jiménez R.M. J. Chromatogr. A. 949:2002;49.
21. Grevel J., Thomas P., Whiting B. Clin. Pharmacokinet. 17:1989;53.
22. Norris R.J., Lee E.H., Sanders S.W. J. Cardiovasc. Pharmacol. 8:1986;91S.
23. Brunner H.R. Am. J. Hypertens. 10:1997;311S.
24. Powell J.R., Reeves R.A., Marino M.R., Cazaubon C., Nisato D. Cardiovascular Drug Rev. 16:1998;169.
25. V.P. Shah, Guidance for Industry: Bioanalytical Methods Validation, May 2001, http:/www.fda.gov/cder/guidance/4252fnl.pdf (June 2003).
26. C.J. Drayton (Ed.), Comprehensive Medicinal Chemistry, vol. 6, Pergamon Press, Oxford, 1990.
27. Cagigal E., Gonzaléz L., Alonso R.M., Jiménez R.M. J. Pharm. Biomed. Anal. 26:2001;447.
28. Majors R.E. LC.GC Europe. 16:2003;256.